Harold M. Weintraub | |
---|---|
Born | Harold M. Weintraub June 2, 1945 Newark, New Jersey, United States of America |
Died | March 28, 1995 Seattle, Washington, U.S. |
Education | Harvard University (AB) University of Pennsylvania (MD, PhD) |
Known for | MyoD Control of Cellular differentiation Transcription (genetics) Chromatin structure and function |
Awards | Eli Lilly Award in Biological Chemistry (1982) Outstanding Investigator Grant, National Institutes of Health (1986) Richard Lounsbery Award (1991) Robert J. and Claire Pasarow Foundation Medical Research Award (1991) |
Scientific career | |
Fields | Molecular biology Developmental Biology |
Institutions | MRC Laboratory of Molecular Biology Princeton University Fred Hutchinson Cancer Research Center University of Washington |
Doctoral advisor | Howard Holtzer, Ph.D. |
Harold M. "Hal" Weintraub was an American scientist who lived from 1945 until his death in 1995 from an aggressive brain tumor. Only 49 years old, Weintraub left behind a legacy of research. [1] [2] [3]
Born on June 2, 1945, in Newark, New Jersey, Weintraub's childhood revolved around sports, including basketball, an activity he would continue to particularly relish throughout his adult life. Weintraub was also the pitcher for an all-city high school baseball team, and a football fullback. [4]
Weintraub attended Harvard College, obtaining his bachelor's degree in 1967. [4] He then proceeded to the University of Pennsylvania, where he earned his M.D. and Ph.D. in 1972. [4] Weintraub performed his Ph.D. dissertation research in the laboratory of Howard Holtzer, [5] studying red blood cell development and production (erythropoeisis) in chicken embryos. This work included the study of cell cycle kinetics, hemoglobin synthesis, and the control of cell division. [6] The effects of bromodeoxyuridine on cell differentiation (conversion of a primitive cell into a more specialized cell) were also analyzed. [7] While still only a graduate student, Weintraub's early work contributed significantly to the fields of developmental and cellular biology, yielding numerous peer-reviewed publications and setting the stage for the next chapter in his research explorations. [1]
During his abbreviated career, Weintraub was the author of more than 130 scientific articles, most of which were in top-tier, peer-reviewed journals, including the "Big 3" basic science journals: Cell, Science, and Nature. [8] Weintraub was a member of the National Academy of Sciences, [9] and served as editorial advisor for numerous journals. [4]
Weintraub spent approximately a year at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England, doing a postdoctoral fellowship in the laboratories of Sydney Brenner and Francis Crick. There, his studies of the nucleosome — a basic unit of DNA packaging — showed that its structure was altered when genes were actively transcribed. [1] Weintraub returned to the United States, and between the years 1973–1977 was an assistant professor at Princeton University. [10] His research at Princeton, which would continue during his years in Seattle, applied enzymatic and traditional biochemical isolation/separation techniques to clarify the relationship between the physical structure of genes and their expression (the process by which DNA is transcribed into messenger RNA, and eventually into Protein.) [11] Another avenue of research in Weintraub's lab studied the effects of oncoviruses on cellular gene expression. [12]
In 1978, Weintraub joined the Fred Hutchinson Cancer Research Center (FHCRC), established in 1971 as an independent affiliate of the University of Washington (UW), Seattle. He was a founding member of the Basic Sciences Division, and professor of genetics at UW. As described in an essay by Marc Kirschner, one of his former colleagues at Princeton, "When most of us left [Princeton] in the late 1970s, Hal, typically concerned more with research opportunity than with glamour, went to a young research institution where the practice of science would be paramount." [2] Weintraub remained at "the Hutch" (the nickname for FHCRC) until his death in 1995. In addition, from 1990 to 1995 Weintraub was a Howard Hughes Medical Institute Investigator. [13]
While at FHCRC, Weintraub continued and extended his prior studies of chromatin structure and function. [14] [15] [16] [17] Another of his contributions was developing the technique of using antisense RNA to create specific mutant phenotypes in vertebrate organisms. [18] [19] Perhaps the work for which Weintraub is best known was his laboratory's discovery and characterization of "myoD", the first master regulatory gene. When expressed, the myoD gene produces a protein referred to as MyoD (or MyoD1), which can bind certain DNA sequences, stop cell division, and elicit an entire program of muscle cell differentiation. In a series of sequential experiments, Weintraub and his students showed that myoD was able to convert fibroblasts (connective tissue cells) into myoblasts (skeletal muscle cells). [20] [21] Later studies by the same group of investigators at FHCRC further characterized the structural and functional characteristics of myoD and its nuclear-localized protein product, [22] [23] which were found to be present in organisms as diverse as nematode worms, frogs, mice, and humans. [24] During the final years of his life, Weintraub's work used myoD to delve broadly and deeply into the areas of regulatory proteins, gene expression, and the molecular control of cell differentiation. [25] [26] [27] [28] [29] [30] [31] As part of this work, his lab pioneered a molecular biology technique known as the Selection And Amplification Binding (SAAB) assay, which is used to find the DNA-binding sites for proteins. [32]
Along with chemist Peter Dervan of Caltech and developmental biologist Doug Melton of Harvard, Weintraub was one of three core scientific advisors to Michael L. Riordan, founder of Gilead Sciences, helping to establish the company's scientific vision at its founding during the late 1980s.
Weintraub died on March 28, 1995, in Seattle, Washington, as a result of complications from glioblastoma multiforme, a very aggressive and fast-growing brain tumor. [10] He had only been diagnosed six months beforehand, undergoing neurosurgery in an attempt to curb its spread. [3] Weintraub was survived by his wife and two sons. [2] In the years that followed, several items were created in his memory:
Exodeoxyribonuclease V is an enzyme of E. coli that initiates recombinational repair from potentially lethal double strand breaks in DNA which may result from ionizing radiation, replication errors, endonucleases, oxidative damage, and a host of other factors. The RecBCD enzyme is both a helicase that unwinds, or separates the strands of DNA, and a nuclease that makes single-stranded nicks in DNA. It catalyses exonucleolytic cleavage in either 5′- to 3′- or 3′- to 5′-direction to yield 5′-phosphooligonucleotides.
Richard Axel is an American molecular biologist and university professor in the Department of Neuroscience at Columbia University and investigator at the Howard Hughes Medical Institute. His work on the olfactory system won him and Linda Buck, a former postdoctoral research scientist in his group, the Nobel Prize in Physiology or Medicine in 2004.
MyoD, also known as myoblast determination protein 1, is a protein in animals that plays a major role in regulating muscle differentiation. MyoD, which was discovered in the laboratory of Harold M. Weintraub, belongs to a family of proteins known as myogenic regulatory factors (MRFs). These bHLH transcription factors act sequentially in myogenic differentiation. Vertebrate MRF family members include MyoD1, Myf5, myogenin, and MRF4 (Myf6). In non-vertebrate animals, a single MyoD protein is typically found.
Robert G. Roeder is an American biochemist. He is known as a pioneer scientist in eukaryotic transcription. He discovered three distinct nuclear RNA polymerases in 1969 and characterized many proteins involved in the regulation of transcription, including basic transcription factors and the first mammalian gene-specific activator over five decades of research. He is the recipient of the Gairdner Foundation International Award in 2000, the Albert Lasker Award for Basic Medical Research in 2003, and the Kyoto Prize in 2021. He currently serves as Arnold and Mabel Beckman Professor and Head of the Laboratory of Biochemical and Molecular Biology at The Rockefeller University.
Michael Stuart Brown ForMemRS NAS AAA&S APS is an American geneticist and Nobel laureate. He was awarded the Nobel Prize in Physiology or Medicine with Joseph L. Goldstein in 1985 for describing the regulation of cholesterol metabolism.
Myogenin, is a transcriptional activator encoded by the MYOG gene. Myogenin is a muscle-specific basic-helix-loop-helix (bHLH) transcription factor involved in the coordination of skeletal muscle development or myogenesis and repair. Myogenin is a member of the MyoD family of transcription factors, which also includes MyoD, Myf5, and MRF4.
Myogenic regulatory factors (MRF) are basic helix-loop-helix (bHLH) transcription factors that regulate myogenesis: MyoD, Myf5, myogenin, and MRF4.
An E-box is a DNA response element found in some eukaryotes that acts as a protein-binding site and has been found to regulate gene expression in neurons, muscles, and other tissues. Its specific DNA sequence, CANNTG, with a palindromic canonical sequence of CACGTG, is recognized and bound by transcription factors to initiate gene transcription. Once the transcription factors bind to the promoters through the E-box, other enzymes can bind to the promoter and facilitate transcription from DNA to mRNA.
Histone-binding protein RBBP4 is a protein that in humans is encoded by the RBBP4 gene.
Pre-B-cell leukemia transcription factor 1 is a protein that in humans is encoded by the PBX1 gene. The homologous protein in Drosophila is known as extradenticle, and causes changes in embryonic development.
Egl nine homolog 2 is a protein that in humans is encoded by the EGLN2 gene. ELGN2 is an alpha-ketoglutarate-dependent hydroxylase, a superfamily of non-haem iron-containing proteins.
Homeobox protein Hox-B5 is a protein that in humans is encoded by the HOXB5 gene.
Homeobox protein Hox-A7 is a protein that in humans is encoded by the HOXA7 gene.
MAD protein is a protein that in humans is encoded by the MXD1 gene.
In molecular biology, a displacement loop or D-loop is a DNA structure where the two strands of a double-stranded DNA molecule are separated for a stretch and held apart by a third strand of DNA. An R-loop is similar to a D-loop, but in this case the third strand is RNA rather than DNA. The third strand has a base sequence which is complementary to one of the main strands and pairs with it, thus displacing the other complementary main strand in the region. Within that region the structure is thus a form of triple-stranded DNA. A diagram in the paper introducing the term illustrated the D-loop with a shape resembling a capital "D", where the displaced strand formed the loop of the "D".
MyoD family inhibitor is a protein that in humans is encoded by the MDFI gene.
Notch proteins are a family of type-1 transmembrane proteins that form a core component of the Notch signaling pathway, which is highly conserved in metazoans. The Notch extracellular domain mediates interactions with DSL family ligands, allowing it to participate in juxtacrine signaling. The Notch intracellular domain acts as a transcriptional activator when in complex with CSL family transcription factors. Members of this Type 1 transmembrane protein family share several core structures, including an extracellular domain consisting of multiple epidermal growth factor (EGF)-like repeats and an intracellular domain transcriptional activation domain (TAD). Notch family members operate in a variety of different tissues and play a role in a variety of developmental processes by controlling cell fate decisions. Much of what is known about Notch function comes from studies done in Caenorhabditis elegans (C.elegans) and Drosophila melanogaster. Human homologs have also been identified, but details of Notch function and interactions with its ligands are not well known in this context.
Homeobox protein Hox-A2 is a protein that in humans is encoded by the HOXA2 gene.
Myogenic factor 5 is a protein that in humans is encoded by the MYF5 gene. It is a protein with a key role in regulating muscle differentiation or myogenesis, specifically the development of skeletal muscle. Myf5 belongs to a family of proteins known as myogenic regulatory factors (MRFs). These basic helix loop helix transcription factors act sequentially in myogenic differentiation. MRF family members include Myf5, MyoD (Myf3), myogenin, and MRF4 (Myf6). This transcription factor is the earliest of all MRFs to be expressed in the embryo, where it is only markedly expressed for a few days. It functions during that time to commit myogenic precursor cells to become skeletal muscle. In fact, its expression in proliferating myoblasts has led to its classification as a determination factor. Furthermore, Myf5 is a master regulator of muscle development, possessing the ability to induce a muscle phenotype upon its forced expression in fibroblastic cells.
Margaret Buckingham, is a British developmental biologist working in the fields of myogenesis and cardiogenesis. She is an honorary professor at the Pasteur Institute in Paris and emeritus director in the Centre national de la recherche scientifique (CNRS). She is a member of the European Molecular Biology Organization, the Academia Europaea and the French Academy of Sciences.